Lockheed Martin has announced the formation of a new healthcare technology alliance, combining the expertise of leading health IT providers, medical technology companies, and academic institutions to advance public health. As part of the alliance, Big Cloud Analytics, Inc. (BCA), a leading provider of real-time predictive analytics technology will work with Intel Corporation to create Internet of Things (IoT) solutions for the new Lockheed Martin Healthcare Technology Alliance.
Alliance Details
The alliance will highlight solutions co-developed by BCA and Intel that incorporate the use of sensors and wearable devices with other data streams to facilitate the collection of patient level data and associated analytic platforms and tools for better understanding individual and population health. The jointly developed solutions originate with BCA’s real-time health analytics platform powered by COVALENCE™ technology, a patent pending customer intelligence engine, which runs on the Intel® Internet of Things (IoT) Gateway. Currently, global insurers leverage the platform to measure the well-being of their insured by examining such factors as the effects that environmental weather patterns have on behavior or the correlations of activity levels to sleep quality.
The solutions, which will require incorporating information gathered at the population level with the many unique characteristics, needs and preferences of individual patients, will be offered to healthcare industry providers, payers, pharmaceutical companies and governmental agencies.
Founding Members
The Lockheed Martin Healthcare Technology Alliance’s founding members include:
– Cisco
– Cloudera
– Illumina
– Intel
– Montgomery College.
Alliance partners are already making progress on complex health information technology solutions. Lockheed Martin and Illumina are collaborating to develop tailored solutions for national-scale genomics programs. Lockheed Martin systems integration and data analytics experience complements Illumina’s recognized leadership in genomic sequencing and analysis. This collaboration has the potential to create a complete offering for customers — the most advanced tools and best practices in large-scale genomic solutions.
Headquartered in Bethesda, Maryland, Lockheed Martin is a global security and aerospace company that employs approximately 112,000 people worldwide and is principally engaged in the research, design, development, manufacture, integration and sustainment of advanced technology systems, products and services.
For additional information on the alliance, please visit www.lockheedmartin.com/hta.
